Ken Tajima

1.5k total citations
38 papers, 927 citations indexed

About

Ken Tajima is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ken Tajima has authored 38 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Ken Tajima's work include Lung Cancer Treatments and Mutations (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Bone and Dental Protein Studies (5 papers). Ken Tajima is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and Bone and Dental Protein Studies (5 papers). Ken Tajima collaborates with scholars based in Japan, United States and Spain. Ken Tajima's co-authors include Kazuhisa Takahashi, Fumiyuki Takahashi, Shyamala Maheswaran, Shin‐ichiro Iwakami, Fariz Nurwidya, Muneaki Hashimoto, Takeshi Nara, Naoko Shimada, Akiko Murakami and Isao Kobayashi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ken Tajima

38 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ken Tajima Japan 17 498 328 295 240 57 38 927
Guoqing Ru China 17 463 0.9× 272 0.8× 232 0.8× 262 1.1× 38 0.7× 70 941
Chelsea Mayoh Australia 19 549 1.1× 267 0.8× 248 0.8× 286 1.2× 29 0.5× 59 1.1k
Shuqin Jia China 17 429 0.9× 235 0.7× 198 0.7× 311 1.3× 22 0.4× 47 847
Gonzalo Lopez United States 15 505 1.0× 160 0.5× 174 0.6× 201 0.8× 37 0.6× 21 721
Laurence Maggiorella France 11 340 0.7× 291 0.9× 115 0.4× 153 0.6× 32 0.6× 17 793
Eva Colás Spain 21 624 1.3× 231 0.7× 185 0.6× 408 1.7× 23 0.4× 42 1.2k
Xian Liu China 16 388 0.8× 294 0.9× 230 0.8× 300 1.3× 18 0.3× 26 824
Ján Remšík United States 14 441 0.9× 356 1.1× 223 0.8× 269 1.1× 18 0.3× 33 977
Sophie Giusiano France 14 332 0.7× 174 0.5× 130 0.4× 120 0.5× 46 0.8× 36 652
Abdo J. Najy United States 14 367 0.7× 222 0.7× 111 0.4× 180 0.8× 22 0.4× 23 618

Countries citing papers authored by Ken Tajima

Since Specialization
Citations

This map shows the geographic impact of Ken Tajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Tajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Tajima more than expected).

Fields of papers citing papers by Ken Tajima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Tajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Tajima. The network helps show where Ken Tajima may publish in the future.

Co-authorship network of co-authors of Ken Tajima

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Tajima. A scholar is included among the top collaborators of Ken Tajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Tajima. Ken Tajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shukuya, Takehito, Kana Kurokawa, Ikuko Nakamura, et al.. (2024). Second malignancy in advanced or recurrent non‐small cell lung cancer after the advent of molecular targeted drugs and immunotherapy. Thoracic Cancer. 15(32). 2291–2297. 1 indexed citations
2.
3.
Mitsuishi, Yoichiro, Wira Winardi, Moulid Hidayat, et al.. (2024). Anti‐Müllerian hormone type II receptor protein expression in non‐small cell lung cancer and the effect of AMH/AMHR2 signaling on cancer cell proliferation. Thoracic Cancer. 15(29). 2090–2099. 1 indexed citations
4.
Hayashi, Takuo, Isamu Watanabe, Kazuya Takamochi, et al.. (2023). Comparison of ASCL1, NEUROD1, and POU2F3 expression in surgically resected specimens, paired tissue microarrays, and lymph node metastases in small cell lung carcinoma. Histopathology. 82(6). 860–869. 13 indexed citations
5.
Miura, Keita, Takehito Shukuya, Sonoko Harada, et al.. (2023). Early Detection of Therapeutic Benefit from PD-1/PD-L1 Blockade in Advanced Lung Cancer by Monitoring Cachexia-Related Circulating Cytokines. Cancers. 15(4). 1170–1170. 1 indexed citations
6.
Suina, Kentaro, Takehito Shukuya, Fumiyuki Takahashi, et al.. (2023). CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma. Thoracic Cancer. 14(12). 1089–1097. 6 indexed citations
7.
Shukuya, Takehito, Tetsuhiko Asao, Daisuke Hayakawa, et al.. (2022). Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer—is there a “tail plateau” in the survival curve of these patients?. BMC Cancer. 22(1). 323–323. 20 indexed citations
8.
Ando, Jun, Midori Ishii, Yoichiro Mitsuishi, et al.. (2021). SCLC-J1, a novel small cell lung cancer cell line. Biochemistry and Biophysics Reports. 27. 101089–101089. 4 indexed citations
9.
Ihara, Hiroaki, Kan Kikuchi, Shogo Fujita, et al.. (2019). 23-valent pneumococcal polysaccharide vaccine improves survival in dialysis patients by preventing cardiac events. Vaccine. 37(43). 6447–6453. 12 indexed citations
10.
Tajima, Ken, Satoru Matsuda, Toshifumi Yae, et al.. (2019). SETD1A protects from senescence through regulation of the mitotic gene expression program. Nature Communications. 10(1). 2854–2854. 39 indexed citations
11.
Takahashi, Fumiyuki, Motoyasu Kato, Yoichiro Mitsuishi, et al.. (2018). Dasatinib Suppresses TGFβ-Mediated Epithelial–Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis. Lung. 196(5). 531–541. 20 indexed citations
12.
Nakamura, Kota, Motoyasu Kato, Takehito Shukuya, et al.. (2017). Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study. BMC Cancer. 17(1). 302–302. 11 indexed citations
13.
Ihara, Hiroaki, Ken Tajima, Norihiro Harada, et al.. (2016). Autofluorescence imaging bronchoscopy as a novel approach to the management of tracheobronchopathia osteochondroplastica: a case report. Journal of Thoracic Disease. 8(10). E1195–E1198. 9 indexed citations
14.
Yagishita, Shigehiro, Ken Tajima, Fumiyuki Takahashi, et al.. (2016). LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer. Biochemistry and Biophysics Reports. 9. 86–94. 10 indexed citations
15.
Murakami, Akiko, Fumiyuki Takahashi, Fariz Nurwidya, et al.. (2014). Hypoxia Increases Gefitinib-Resistant Lung Cancer Stem Cells through the Activation of Insulin-Like Growth Factor 1 Receptor. PLoS ONE. 9(1). e86459–e86459. 105 indexed citations
16.
Takahashi, Fuminori, Naokazu Chiba, Ken Tajima, et al.. (2011). Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib. Oncogene. 30(27). 3084–3095. 50 indexed citations
17.
Tajima, Ken, Yoshitaka Sekido, Toyoaki Hida, et al.. (2010). Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells. Oncogene. 29(13). 1941–1951. 41 indexed citations
18.
Ohashi, Rina, Ken Tajima, Ri Cui, et al.. (2009). Osteopontin Modulates Malignant Pleural Mesothelioma Cell Functions in Vitro. Haigan. 49(4). 368–375. 13 indexed citations
19.
Gu, Tao, Rina Ohashi, Ri Cui, et al.. (2009). Osteopontin is involved in the development of acquired chemo-resistance of cisplatin in small cell lung cancer. Lung Cancer. 66(2). 176–183. 44 indexed citations
20.
Takahashi, Fumiyuki, Michie Toba, Kazuhisa Takahashi, et al.. (2006). Pulmonary sarcoidosis and antiphospholipid syndrome. Respirology. 11(4). 506–508. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guoqing Ru Breakdown of academic impact, for papers by Chelsea Mayoh Breakdown of academic impact, for papers by Shuqin Jia Breakdown of academic impact, for papers by Gonzalo Lopez Breakdown of academic impact, for papers by Laurence Maggiorella Breakdown of academic impact, for papers by Eva Colás Breakdown of academic impact, for papers by Xian Liu Breakdown of academic impact, for papers by Ján Remšík Breakdown of academic impact, for papers by Sophie Giusiano Breakdown of academic impact, for papers by Abdo J. Najy
Rankless by CCL
2026